165 related articles for article (PubMed ID: 7872745)
1. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.
Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1994 Nov; 38(11):2545-52. PubMed ID: 7872745
[TBL] [Abstract][Full Text] [Related]
2. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
3. Polyamine metabolism in Pneumocystis carinii.
Lipschik GY; Masur H; Kovacs JA
J Infect Dis; 1991 May; 163(5):1121-7. PubMed ID: 2019760
[TBL] [Abstract][Full Text] [Related]
4. Ornithine decarboxylase as an enzyme target for therapy.
McCann PP; Pegg AE
Pharmacol Ther; 1992; 54(2):195-215. PubMed ID: 1438532
[TBL] [Abstract][Full Text] [Related]
5. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
7. Regulation of diamine oxidase expression by ornithine decarboxylase in isolated rat small bowel enterocytes.
D'Agostino L; Pignata S; Daniele B; Ferraro C; D'Adamo G; Tritto G; Mazzacca G
Digestion; 1990; 46 Suppl 2():403-9. PubMed ID: 2124562
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
Geck RC; Foley JR; Murray Stewart T; Asara JM; Casero RA; Toker A
J Biol Chem; 2020 May; 295(19):6263-6277. PubMed ID: 32139506
[TBL] [Abstract][Full Text] [Related]
9. Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia.
Chin K; Merali S; Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1996 Oct; 40(10):2318-20. PubMed ID: 8891137
[TBL] [Abstract][Full Text] [Related]
10. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites.
Poulin R; Lu L; Ackermann B; Bey P; Pegg AE
J Biol Chem; 1992 Jan; 267(1):150-8. PubMed ID: 1730582
[TBL] [Abstract][Full Text] [Related]
13. Ornithine decarboxylase induction and polyamine synthesis in the kindling of seizures: the effect of alpha-difluoromethylornithine.
Herberg LJ; Rose IC; de Belleroche JS; Mintz M
Epilepsy Res; 1992 Mar; 11(1):3-7. PubMed ID: 1563337
[TBL] [Abstract][Full Text] [Related]
14. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
Selamnia M; Mayeur C; Robert V; Blachier F
Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi as a model system to study the expression of exogenous genes coding for polyamine biosynthetic enzymes. Induction of DFMO resistance in transgenic parasites.
Carrillo C; González NS; Algranati ID
Biochim Biophys Acta; 2007 Dec; 1770(12):1605-11. PubMed ID: 17920200
[TBL] [Abstract][Full Text] [Related]
16. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
17. Involvement of antizyme in stabilization of ornithine decarboxylase caused by inhibitors of polyamine synthesis.
Murakami Y; Nishiyama M; Hayashi S
Eur J Biochem; 1989 Mar; 180(1):181-4. PubMed ID: 2495941
[TBL] [Abstract][Full Text] [Related]
18. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
Hsu HC; Thomas T; Seibold JR; Thomas TJ
Agents Actions; 1993; 39 Spec No():C204-6. PubMed ID: 8273569
[TBL] [Abstract][Full Text] [Related]
19. On the translational control of ornithine decarboxylase expression by polyamines.
Stjernborg L; Heby O; Holm I; Persson L
Biochim Biophys Acta; 1991 Oct; 1090(2):188-94. PubMed ID: 1932110
[TBL] [Abstract][Full Text] [Related]
20. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
